AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Iovance Biotherapeutics, Inc.

$8.48 +$5.96 (+236.51%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$9.56
Day Range
$8.27$9.17
Year Range
$1.76$15.37
Market Cap
3.84B
AVG Volume
16.9M
Trailing/Forward PE
-11.62/-
PEG ratio
0.2
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IOVA Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2324.97M
26 Q1285.61M
25 Q4263.5M
25 Q3250.43M
25 Q2241.52M
25 Q1212.68M
24 Q4164.07M
24 Q390.86M
24 Q232.77M
24 Q11.9M
Net Income (USD) · TTM
-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IOVA Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-289.52M
26 Q1-353.86M
25 Q4-390.98M
25 Q3-397.63M
25 Q2-389.92M
25 Q1-375.36M
24 Q4-372.18M
24 Q3-410M
24 Q2-440.22M
24 Q1-449.64M
Operating Income (USD) · TTM
-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IOVA Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-301.31M
26 Q1-363.18M
25 Q4-403.36M
25 Q3-416.47M
25 Q2-410.64M
25 Q1-398.78M
24 Q4-395.28M
24 Q3-429.96M
24 Q2-459.25M
24 Q1-467.43M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: IOVA

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Iovance Biotherapeutics, Inc.
IOVA
Stockpicker

Video analysis: IOVA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: IOVA

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.